China is offering an experimental “emergency-use” coronavirus vaccine that has yet to pass standard testing to students heading overseas to study, according to reports.
The state-owned China National Biotec Group Co. made the offer on its website to administer the unproven shot for free — with many students already accepting the offer, according to the Wall Street Journal.
They are being offered “emergency-use” approval, which was supposed to be reserved for those most at risk, such as medical workers and customs staff.
China National Biotec Group’s parent company, Sinopharm, said on its website Monday that 481,613 people had already taken one of its yet-to-be-approved vaccines while another 93,653 had applied and were waiting, the report said.
“This would indeed be expanding the granted emergency use permit to beyond their intent,” Nigel McMillan, director of the infectious diseases and immunology program at Griffith University’s Menzies Health Institute Queensland in Australia, told Bloomberg.
“While obviously very important to the families and